This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ozempic and Wegovy are injectable prescription weight-loss medicines made by Danish ...

Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...

Indian firms such as Ajanta Pharma, Dr Reddy's Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals are poised to fulfil domestic demand for weight-loss drugs with more affordable generic ...

The upcoming expiry of the semaglutide patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the ...

New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in what they describe as “one of the most egregious examples of ...

NASHVILLE, Tenn. — The Tennessee Attorney General's Office announced that states across the country reached new settlements totaling $17.85 million with two drug companies over alleged generic ...

JDK 27, due in September, kicks off with a post-quantum hybrid key exchange proposal to bolster the security of network communications. Java Development Kit (JDK) 27, a release of standard Java ...

Credit: Cosette Pharmaceuticals Cosette’s Ciprofloxacin Hydrochloride 0.2% and Hydrocortisone 1% Otic Suspension is supplied as a suspension in a 10mL bottle with a dropper dispenser. A generic option ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to ...